Skip to main content
Skip to main content
Header Nav
  • About
  • Products
  • Pipeline
  • Impact
  • Investors
  • Careers
  • Contact us
Investors Menu
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Policies and Charters
    • Board Committee Assignments
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Analyst Coverage
  • Investor FAQs
  • Contact IR

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
01/10/2023
Document Date
01/09/2023
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Eagle Pharmaceuticals, Inc.
Issuer
EAGLE PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
Change % Volume Data as of 03/13/2023 9:16 AM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Policies and Charters
    • Board Committee Assignments
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Analyst Coverage
  • Investor FAQs
  • Contact IR
Sidebar Links
  • Email Alerts
  • RSS Feeds

Investor Contact

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.

Footer Links
  • privacy policy
  • terms of use
  • sitemap
  • contact us
© 2023 Eagle Pharmaceuticals, Inc. All rights reserved. Woodcliff Lake, NJ 07677